Search

for
Search:

Research

5 / 1000+ results

research Clinical Diagnosis of Common Scalp Disorders

61 citations , October 2005 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings”

This review discusses scalp skin disorders, their overlapping symptoms, diagnostic techniques, and treatment strategies, emphasizing the importance of accurate differential diagnosis, but reports no new clinical results.

Clinical Diagnosis of COVID-19: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis)

research Clinical Diagnosis of COVID-19: a Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis).

1 citations , January 2021 in “Research Square (Research Square)”

This study found that the AndroCoV Clinical Scoring for COVID-19 Diagnosis may offer a more sensitive and timely diagnostic tool for COVID-19 than conventional rtPCR testing, especially enhancing potential treatment timing.

Clinical Diagnosis of COVID-19: A Prompt, Feasible, and Sensitive Diagnostic Tool Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis)

research Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis)

1 citations , January 2021 in “medRxiv (Cold Spring Harbor Laboratory)”

This study reports that the AndroCoV Clinical Scoring for COVID-19 Diagnosis provides a quicker, more sensitive, and inexpensive alternative to rtPCR-SARS-CoV-2 with an accuracy above 80% in diagnosing COVID-19.

research Artificial Intelligence in Dermatology: Assessing Predictability in Clinical Diagnosis

September 2025 in “The Open Dermatology Journal”

In this study, the Tibot AI application showed high diagnostic accuracy for adnexal and pigmentary disorders and cutaneous tumors in dermatology, but was less effective for immunological disorders and infestations, suggesting the need for further dataset refinement.

research Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis).

December 2020 in “Research Square (Research Square)”

This study found that the AndroCoV Clinical Scoring for COVID-19 Diagnosis is a feasible, sensitive, and cost-effective tool with higher accuracy than most rtPCR-SARS-CoV-2 tests for diagnosing COVID-19.

View more "clinical diagnosis" in research →

Community Join

5 / 1000+ results

community Why Hair Loss Needs Proper Diagnosis (Dermatologist Insight)

in Treatment 66 upvotes 7 months ago

Hair loss requires proper diagnosis as it can have various causes, and treatments like finasteride, minoxidil, and dutasteride are often used. Many people express frustration with dermatologists and turn to self-research and alternative sources for treatment.

community Diagnosed with MPB at 16 (Male)

50 upvotes 2 years ago

A 16-year-old diagnosed with male pattern baldness (MPB) was prescribed hair vitamins, vitamin D, a non-ketoconazole shampoo, and redenysl + serum, with a suggestion for GFC or IHRF treatments. Some users recommended minoxidil, ketoconazole, and derma stamping, while others advised against certain treatments until the age of 18.

community Hair loss after COVID or vaccination isn’t “made up” but it’s also not what TikTok makes it sound like

2 upvotes 8 months ago

COVID and COVID vaccination can trigger hair loss, primarily telogen effluvium, due to stress and immune system activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.

community Article of all potential future cures

25 upvotes 1 year ago

Ritlecitinib and PP405 show promise for hair regrowth. Diagnosing the cause of hair loss is crucial before treatment.

community Dutasteride Isn't Working? Get a Scalp Biopsy NOW

in Finasteride/Dutasteride 19 upvotes 1 year ago

Dutasteride may not be effective for everyone due to underlying issues, suggesting scalp biopsies for further diagnosis. Users discuss using higher doses of dutasteride, topical treatments, minoxidil, and pyrilutamide for hair loss management.

View more "clinical diagnosis" in community →

Clinics

1 / 9 results

56
Trichology
Hair Clinic - Trichological Diagnosis & Hair and Scalp Treatment Tel Aviv BranchTel Aviv-Yafo · IL

Learn

7 / 801 results

learn Overview

learn Thymosin Beta 4

learn KY19382

Are there clinical studies showing that KY19382 can regrow hair in androgenic alopecia? No clinical studies have proven KY19382 regrows hair in androgenic alopecia.

learn SCUBE3

What do clinical trials say about the safety and effectiveness of SCUBE3 for hair regrowth? No clinical trial of SCUBE3 for hair regrowth has been registered on ClinicalTrials.gov or published, so there is no human safety or effectiveness data. The evidence is limited to one 2022 laboratory and mouse study reporting that SCUBE3 activates hair follicle stem cells through TGF-beta signalling.

learn Follistatin

Are there any clinical studies supporting follistatin as a hair loss treatment? There is no controlled human trial showing follistatin treats hair loss; the published work is mouse and laboratory biology on the activin/follistatin signalling system, plus one small 2011 phase 1 injection study of a combination product, so follistatin remains experimental and unapproved.

learn Tofacitinib

What types of hair loss conditions are most commonly associated with tofacitinib use in clinical settings? Published studies link tofacitinib mainly to alopecia areata and its severe variants — as an off-label drug being studied for them, not as a cause of hair loss. The evidence is mostly small, open-label or retrospective, and relapse after stopping is commonly reported.

learn GT20029

When will GT20029 be commercially available, and are there any clinical trials on its use? GT20029 is not approved or commercially available anywhere and remains investigational. A published 12-week Phase II study in 180 Chinese men reports hair-count gains over placebo, but no long-term or Phase III data exists, so any launch is years away at best.

View more "clinical diagnosis" in learn →

Experts

— no results

Try a deeper search in experts →